Personal finance company Credit Karma is focusing on helping consumers understand financial resources available to them amid the COVID-19 crisis, CEO Kenneth Lin told Cheddar Thursday. 

Lin said the company is tracking both government and private aid to help keep its customers informed. 

"When there are forgiveness programs, we want to make sure consumers are out in front of them and know that they're available to help them," he said. "One of the things we're trying to understand, and assessing, is can we track all of the programs that are available." 

Lin said he expects dozens, if not hundreds, of programs "for the average consumer" and said it will be "a big challenge" weeding through them in order to find the ones its customers will qualify for.

Credit Karma, founded in 2007 and "born in the last recession," according to Lin, is seeing more usage and engagement, even as the economy falters and unemployment claims continue to rise. 

"What we are seeing across the industry is more consumers are looking for personal loans… more and more people are looking for mortgages," he said, though Lin said there aren't enough people in call centers or appraisers to get users through the processes. 

"So, while rates are low, the system is somewhat frozen," he said. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More